RAVI Performance — FlexShares Ultra-Short Income Fund
Data updated: 2026-09-25
RAVI returned +2.10% year to date and +4.21% over one year to Jul 2026. Annualised returns are +5.09% over 3 years and +3.60% over 5 years. The fund trailed its Ultrashort Corporate Bond category average: $100 invested three years ago grew to $116, against $122 for the category, and to $104 over one year, against $106. Volatility over the past three years was 0.38% a year. In the 12 months to Jul 2026 the fund took in a net $156.7M, and assets reached $1.49B.
RAVI Growth of $100
What $100 invested in FlexShares Ultra-Short Income Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Ultrashort Corporate Bond category average over the same months.
| Period | RAVI | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $104 | $106 |
| 3 years (Aug 2023 – Jul 2026) | $116 | $122 |
| 5 years (Aug 2021 – Jul 2026) | $119 | $127 |
| Since data start (Aug 2019 – Jul 2026) | $123 | $135 |
RAVI Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +2.10% |
| 1 year | +4.21% |
| 3 years (annualised) | +5.09% |
| 5 years (annualised) | +3.60% |
RAVI Annual Returns
Calendar-year total returns of FlexShares Ultra-Short Income Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | +2.10% |
| 2025 | +4.95% |
| 2024 | +5.68% |
| 2023 | +5.54% |
| 2022 | +0.14% |
| 2021 | −0.02% |
| 2020 | +2.04% |
| 2019 (Aug–Dec) | +1.10% |
RAVI Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +0.3% | +0.3% | 0.0% | +0.4% | +0.4% | +0.3% | +0.3% | — | — | — | — | — |
| 2025 | +0.4% | +0.5% | +0.4% | +0.2% | +0.4% | +0.5% | +0.4% | +0.5% | +0.4% | +0.4% | +0.3% | +0.4% |
| 2024 | +0.6% | +0.4% | +0.5% | +0.4% | +0.5% | +0.4% | +0.6% | +0.5% | +0.5% | +0.3% | +0.4% | +0.4% |
| 2023 | +0.6% | +0.3% | +0.2% | +0.5% | +0.4% | +0.4% | +0.5% | +0.5% | +0.4% | +0.4% | +0.6% | +0.6% |
| 2022 | −0.2% | −0.2% | −0.4% | −0.2% | +0.1% | −0.3% | +0.2% | +0.2% | −0.1% | +0.1% | +0.5% | +0.5% |
| 2021 | 0.0% | 0.0% | −0.1% | +0.1% | +0.1% | 0.0% | +0.1% | 0.0% | 0.0% | −0.2% | −0.1% | −0.1% |
| 2020 | +0.3% | +0.3% | −1.9% | +1.6% | +0.7% | +0.5% | +0.2% | +0.1% | 0.0% | 0.0% | +0.1% | +0.1% |
| 2019 | — | — | — | — | — | — | — | +0.3% | +0.2% | +0.3% | +0.1% | +0.2% |
RAVI Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 0.38%
- Best month: +0.60% (Nov 2023)
- Worst month: +0.04% (Mar 2026)
RAVI Fund Flows
Monthly money in and out of FlexShares Ultra-Short Income Fund, from SEC Form N-PORT.
- 12-month net flow: $156.7M
- 12-month gross sales (incl. reinvestments): $337.6M
- Sales ÷ redemptions: 1.87×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $60.2M | $17.3M | $42.9M |
| Jun 2026 | $64.7M | $10.5M | $54.2M |
| May 2026 | $9.8M | $15.8M | −$6.0M |
| Apr 2026 | $13.5M | $27.9M | −$14.3M |
| Mar 2026 | $33.9M | $28.6M | $5.3M |
| Feb 2026 | $24.1M | $4.5M | $19.6M |
| Jan 2026 | $27.2M | $15.1M | $12.1M |
| Dec 2025 | $24.9M | $18.1M | $6.8M |
| Nov 2025 | $26.4M | $13.6M | $12.8M |
| Oct 2025 | $2.3M | $15.9M | −$13.6M |
| Sep 2025 | $18.1M | $7.6M | $10.6M |
| Aug 2025 | $32.4M | $6.0M | $26.4M |
RAVI Assets Under Management
Net assets of FlexShares Ultra-Short Income Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $1.49B |
| 2026-04-30 | $1.40B |
| 2026-01-31 | $1.40B |
| 2025-10-31 | $1.37B |
| 2025-07-31 | $1.34B |
| 2025-04-30 | $1.23B |
| 2025-01-31 | $1.20B |
| 2024-10-31 | $1.15B |
| 2024-07-31 | $1.12B |
| 2024-04-30 | $1.14B |
| 2024-01-31 | $1.12B |
| 2023-10-31 | $1.08B |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.